Health
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | NEJM – nejm.org
Correspondence from The New England Journal of Medicine — Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
After emergency use of the mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was authorized, the observer-blinded, pivotal Coronavirus Efficacy (COVE) trial was amended on December 23, 2020, to include an open-label phase in…
Continue Reading
-
General11 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News20 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General18 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News12 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial